M
M. Romanchikova
Researcher at National Physical Laboratory
Publications - 27
Citations - 251
M. Romanchikova is an academic researcher from National Physical Laboratory. The author has contributed to research in topics: Computer science & Medicine. The author has an hindex of 7, co-authored 21 publications receiving 151 citations. Previous affiliations of M. Romanchikova include University of Cambridge & Cambridge University Hospitals NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy.
Leila E.A. Shelley,Leila E.A. Shelley,J.E. Scaife,J.E. Scaife,M. Romanchikova,K. Harrison,K. Harrison,Julia R. Forman,A. Bates,A. Bates,D. Noble,D. Noble,Rajesh Jena,Rajesh Jena,Michael Andrew Parker,Michael Andrew Parker,Michael P.F. Sutcliffe,Michael P.F. Sutcliffe,Simon J. Thomas,Neil G. Burnet,Neil G. Burnet +20 more
TL;DR: Dose–surface maps extracted from accumulated DSMs have demonstrated stronger correlations with rectal bleeding and proctitis, than planned DSMs, and were linked with toxicity to test the hypothesis that delivered dose is a stronger predictor of toxicity than planned dose.
Journal ArticleDOI
REMBI: Recommended Metadata for Biological Images-enabling reuse of microscopy data in biology.
Ugis Sarkans,Wah Chiu,Lucy M. Collinson,Michele C. Darrow,Jan Ellenberg,David Grunwald,Jean-Karim Hériché,Andrii Iudin,Gabriel G. Martins,Terry Meehan,Kedar Narayan,Ardan Patwardhan,Matthew R. G. Russell,Helen R. Saibil,Caterina Strambio-De-Castillia,Jason R. Swedlow,Christian Tischer,Virginie Uhlmann,Paul Verkade,Mary Barlow,Omer Ali Bayraktar,Ewan Birney,Cesare Catavitello,Christopher Cawthorne,Stephan Wagner-Conrad,Elizabeth Duke,Perrine Paul-Gilloteaux,Emmanuel Gustin,Maria Harkiolaki,Pasi Kankaanpää,Thomas Lemberger,Jo McEntyre,Josh Moore,Andrew W. Nicholls,Shuichi Onami,Helen Parkinson,Maddy Parsons,M. Romanchikova,Nicholas James Sofroniew,Jim Swoger,Nadine Utz,Lenard M. Voortman,Frances Wong,Peijun Zhang,Gerard J. Kleywegt,Alvis Brazma +45 more
TL;DR: In this paper, the authors propose metadata guidelines to address the needs of diverse communities within light and electron microscopy within microscopy, and the proposed Recommended Metadata for Biological Images (REMBI) will stimulate discussions about their implementation and future extension.
Journal ArticleDOI
Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancer.
J.E. Scaife,Simon J. Thomas,K. Harrison,M. Romanchikova,Michael P.F. Sutcliffe,Julia R. Forman,A. Bates,Raj Jena,M. Andrew Parker,Neil G. Burnet +9 more
TL;DR: Accumulated dose-volumes were different from planned in all participants and dose–surface maps (DSMs) were able to identify differences between DA and planned dose that could not be appreciated from the DVHs.
Journal ArticleDOI
Anatomical change during radiotherapy for head and neck cancer, and its effect on delivered dose to the spinal cord.
D. Noble,Ping-Lin Yeap,Shannon Y.K. Seah,K. Harrison,Leila E.A. Shelley,M. Romanchikova,A. Bates,Yaolin Zheng,Gillian C. Barnett,R.J. Benson,Sarah Jefferies,Simon J. Thomas,Raj Jena,Neil G. Burnet +13 more
TL;DR: Differences between planned and delivered maximum spinal cord dose were small and there was no link between weight loss or anatomical change, and dose differences was seen.
Journal ArticleDOI
Random variation in rectal position during radiotherapy for prostate cancer is two to three times greater than that predicted from prostate motion.
J.E. Scaife,K. Harrison,M. Romanchikova,A Parker,Michael P.F. Sutcliffe,Simon Bond,Simon J. Thomas,Sue Freeman,Rajesh Jena,A. Bates,Neil G. Burnet +10 more
TL;DR: This work is the first to use daily imaging to quantify systematic and random variation in the position of the rectum in prostate cancer, and σ was found to be greater than published data, suggesting that DA may differ from planned dose in some patients treated with radiotherapy for prostate cancer.